Pharmaceutical Leader to Call for Common European Standards on Cannabis Medicines
A pharmaceutical executive leading work on international cannabis standards will speak at medical cannabis conferences in Frankfurt and London this autumn.

Contributor
Jodie Yettram is a contributing writer at Cannabis Health, covering medical cannabis research, policy, patient access and clinical practice across the UK and Europe. An NCTJ Gold Standard, award-winning journalist from Jersey, her reporting has appeared across multiple Channel Island publications and City AM in London. She has a particular interest in women’s health, mental health and neurodiversity, having campaigned for improvements to women’s healthcare in her local paper and led an investigation into ADHD services. She also won the NCTJ’s Top Scoop award for breaking the news that Jersey’s home-birth service had been suspended.

A pharmaceutical executive leading work on international cannabis standards will speak at medical cannabis conferences in Frankfurt and London this autumn.
Jodie Yettram·

A former Frankfurt drugs official will examine how stigma around cannabis can affect patients receiving it as a medical treatment at a conference in the city next month.
Jodie Yettram·

Whether cannabinoid medicines could offer a better overall treatment option than opioids for some people with chronic pain will be examined at a medical cannabis conference in Frankfurt this November.
Jodie Yettram·

What is actually legal when it comes to medical cannabis in the UK? From prescriptions and possession to driving, smoking and NHS access, here’s what patients need to know about the law in 2026.
Jodie Yettram·

The director of the UK’s only World Anti-Doping Agency-accredited laboratory has been announced as a speaker at a medical cannabis conference in London next month.
Jodie Yettram·

A data and economics specialist working across Germany’s medical cannabis sector will join the Cannabis Health Symposium Frankfurt later this year.
Jodie Yettram·

A senior figure behind one of Germany’s medical cannabis telemedicine platforms has been announced as a speaker at an event hosted by Cannabis Health later this year.
Jodie Yettram·

How do medical cannabis vaporisers work, what are the different types, and what should UK patients know about using them safely?
Jodie Yettram·

Denmark’s medicines regulator found no new safety concerns linked to medical cannabis in 2025 – despite the number of patients receiving prescriptions rising by more than half.
Jodie Yettram·

The founder of the oldest licensed commercial medical cannabis cultivation company in the world is set to speak in Germany as part of an event run by Cannabis Health later this year.
Jodie Yettram·

Could cannabinoids offer an alternative to opioids for people living with chronic pain – and what does the evidence actually show?
Jodie Yettram·

A German court has rejected a woman on benefits with a severe neurological condition from continuing to receive medical cannabis flower through health insurance.
Jodie Yettram·

Women with endometriosis reported less pain and better sleep after taking medical cannabis, according to a UK study.
Jodie Yettram·

What have Germany’s cannabis reforms meant for drug use, public health, young people and the black market?
Jodie Yettram·

Cannabis may help some people with ADHD manage symptoms such as restlessness and impulsivity – but research suggests it could make other symptoms worse.
Jodie Yettram·

Medical cannabis has been legal on prescription in Northern Ireland since 1 November 2018.
Jodie Yettram·

Interest in medical cannabis for autism is growing among patients, families and clinicians, but research has yet to establish whether it is an effective treatment.
Jodie Yettram·

Experts will examine the impact of Germany’s cannabis reforms on patient care, prescribing and access to treatment.
Jodie Yettram·